PNC-27

PNC-27 — frequently asked questions

• What is PNC-27?

  PNC-27 is a synthetic peptide based on residues from the human p53 protein linked to a membrane-penetrating motif. In preclinical research it binds HDM2 localized on cancer-cell membranes and assembles into membrane pores, producing selective on-target cytotoxicity in vitro and in animal models.

• What is the half-life of PNC-27?

  PNC-27 has an approximate half-life of Not well characterized; expected short plasma stability typical of linear peptides (minutes to low hours) without specialized formulation. The half-life determines how often you need to inject to maintain steady blood levels — use the Peptides Calculator half-life calculator to plot your specific dosing schedule and see the decay curve.

• How is PNC-27 administered?

  PNC-27 is typically delivered via preclinical studies have explored intratumoral, perilesional, or topical/locoregional administration; systemic delivery remains investigational.. The Peptides Calculator app helps you reconstitute the vial with bacteriostatic water, calculate your exact dose in syringe units, and track each injection.

• How does PNC-27 work?

  Binds HDM2 on cancer-cell membranes; peptide oligomerization forms transmembrane pores that rapidly disturb ionic gradients and induce necrotic/apoptotic cell death. Selectivity is hypothesized to stem from cancer-specific membrane HDM2 expression.

• What are the researched benefits of PNC-27?

  Studied benefits of PNC-27 include: Potent cytotoxicity against HDM2-positive cancer cells in vitro, Activity reported across multiple tumor cell lines in preclinical studies, Mechanistically distinct from DNA-damaging chemotherapeutics. These are research findings only — Peptides Calculator does not provide medical advice; consult a qualified healthcare professional before starting any peptide protocol.

• What are the side effects of PNC-27?

  Reported side effects of PNC-27 include: Local irritation at administration site (preclinical), Potential off-target membrane toxicity/hemolysis at higher concentrations, Unknown immunogenicity and systemic safety; not clinically approved. Always discuss potential side effects with a licensed healthcare provider before using any research peptide.